Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

C.I. Solvent Yellow 14: Target Organs and Levels of Evidence for TR-226

Carcinogenesis Bioassay of C.I. Solvent Yellow 14 (CASRN 842-07-9) in F344/N Rats and B6C3F1 Mice (Feed Study)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
C.I. Solvent yellow 14 842-07-9	02/18/1981	Dosed-Feed R: 0,250,500, M: 0,500,1000 PPM/50 PER GROUP	Battelle Columbus Laboratory

Levels of Evidence

Male Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: NEOPLASTIC NODULE 5/50 10/50 30/50

Female Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Liver: NEOPLASTIC NODULE 2/50 3/49 10/48

C.I. Solvent Yellow 14: Target Organs and Levels of Evidence for TR-226

Carcinogenesis Bioassay of C.I. Solvent Yellow 14 (CASRN 842-07-9) in F344/N Rats and B6C3F1 Mice (Feed Study)

Levels of Evidence

Male Rats: Positive

Female Rats: Positive

Male Mice: Negative

Female Mice: Negative